Skip to main content
SpringerLink
Log in

ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.

    Article  PubMed  Google Scholar 

  2. Otsubo T, Yamada K, Hagiwara T, et al. DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma. Oncotarget. 2017;8:84434–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nohara K, Yamada K, Yamada L, et al. Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma. Gen Thorac Cardiovasc Surg. 2018;66:351–7.

    Article  PubMed  Google Scholar 

  4. Shimomura A, Hagiwara T, Yamada K, et al. Induction of kallikrein-related peptidase 13 and TET2/3 by anticancer drugs and poor prognosis of patients with esophageal squamous cell carcinoma after preoperative treatment. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14364-9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, National Center for Global Health and Medicine, Tokyo, Japan

    Akira Shimomura MD

  2. Department of General Internal Medicine, National Center for Global Health and Medicine, Tokyo, Japan

    Akira Shimomura MD

  3. Clinical Research Advancement Section, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan

    Akira Shimomura MD & Yuki I. Kawamura PhD

  4. Course of Advanced and Specialized Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

    Akira Shimomura MD & Kazuhiko Yamada MD, PhD, FACS

  5. Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan

    Kazuhiko Yamada MD, PhD, FACS

Authors
  1. Akira Shimomura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuhiko Yamada MD, PhD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuki I. Kawamura PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuki I. Kawamura PhD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimomura, A., Yamada, K. & Kawamura, Y.I. ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 31, 243–244 (2024). https://doi.org/10.1245/s10434-023-14461-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14461-9

Search

Navigation